Phenylephrine Hydrochloride Injection
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Phenylephrine Hydrochloride Injection is a sterile solution of Phenylephrine Hydrochloride in Water for Injection. It contains NLT 90.0% and NMT 115.0% of the labeled amount of phenylephrine hydrochloride (C9H13NO2 · HCl).
2 IDENTIFICATION
Change to read:
A. The retention time of the phenylephrine peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. (USP 1-Aug-2019)
Add the following:
B. The UV absorption spectrum of the phenylephrine peak of the Sample solution exhibits maxima and minima at the same wavelengths as those of the Standard solution, as obtained in the Assay.(USP 1-Aug-2019)
3 ASSAY
Change to read:
Procedure
Solution A: Phosphoric acid and water (1:1000)
Solution B: Acetonitrile
Mobile phase: See Table 1.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
|---|---|---|
| 0 | 98 | 2 |
| 2.5 | 98 | 2 |
| 6 | 65 | 35 |
| 6.1 | 98 | 2 |
| 9 | 98 | 2 |
Standard solution: 0.1 mg/mL of USP Phenylephrine Hydrochloride RS in water
Sample solution: Nominally 0.1 mg/mL of phenylephrine hydrochloride in water from a volume of Injection
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 273 nm. For Identification B, use a diode array detector in the range of 245–400 nm.
Column: 4.6-mm × 15-cm; 2.6-μm packing L1
Column temperature: 35°
Flow rate: 1.0 mL/min
Injection volume: 10 μL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.5
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of phenylephrine hydrochloride (C9H13NO2 · HCl) in the portion of Injection taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of phenylephrine from the Sample solution
rS = peak response of phenylephrine from the Standard solution
CS = concentration of USP Phenylephrine Hydrochloride RS in the Standard solution (mg/mL)
CU = nominal concentration of phenylephrine hydrochloride in the Sample solution (mg/mL)
Acceptance criteria: 90.0%–115.0%
4 IMPURITIES
Add the following:
Organic Impurities
Solution A, Solution B, Mobile phase, and Sample solution: Prepare as directed in the Assay.
System suitability solution: 0.1 mg/mL of USP Phenylephrine Hydrochloride RS and 0.005 mg/mL of USP Phenylephrine Related Compound F RS in water
Sensitivity solution: 0.1 μg/mL of USP Phenylephrine Hydrochloride RS in water
Standard solution: 0.0002 mg/mL of USP Phenylephrine Hydrochloride RS in water
Chromatographic system: Proceed as directed in the Assay, except for the Detector.
Detector: UV 215 nm
System suitability
Samples: System suitability solution, Sensitivity solution, and Standard solution
[Note - The relative retention times for phenylephrine related compound F and phenylephrine are 0.9 and 1.0, respectively.]
Suitability requirements
Resolution: NLT 1.5 between phenylephrine and phenylephrine related compound F, System suitability solution
Relative standard deviation: NMT 5.0%, Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
Samples: Sample solution and Standard solution
Calculate the percentage of each degradation product in the portion of Injection taken:
Result = (rU/rS) × (CS/CU) × (1/F) × 100
rU = peak response of each degradation product from the Sample solution
rS = peak response of phenylephrine from the Standard solution
CS = concentration of USP Phenylephrine Hydrochloride RS in the Standard solution (mg/mL)
CU = nominal concentration of phenylephrine hydrochloride in the Sample solution (mg/mL)
F = relative response factor (see Table 2)
Acceptance criteria: See Table 2.
Table 2
| Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
|---|---|---|---|
| Phenylephrine | 1.0 | 1.0 | – |
| Phenylephrone (phenylephrine related compound C)ᵃ | 1.2 | 2.8 | 0.7 |
| Phenylephrine-citrate adductᵇ | 2.9 | 1.0 | 0.4 |
| Any unspecified degradation product | – | 1.0 | 0.2 |
| Total degradation products | – | – | 1.3 |
a 1-(3-Hydroxyphenyl)-2-(methylamino)ethan-1-one hydrochloride.
b 2-Hydroxy-2-(2-{[(R)-2-hydroxy-2-(3-hydroxyphenyl)ethyl](methyl)amino}-2-oxoethyl)succinic acid.
5 SPECIFIC TESTS
Bacterial Endotoxins Test 〈85〉: It contains NMT 25.0 USP Endotoxin Units/mg of phenylephrine hydrochloride.
pH 〈791〉: 3.0–6.5
Other Requirements: It meets the requirements in Injections and Implanted Drug Products 〈1〉.
6 ADDITIONAL REQUIREMENTS
Change to read:
Packaging and Storage: Preserve in single-dose or multiple-dose containers, preferably of Type I glass, protected from light. Store at controlled room temperature. (USP 1-Aug-2019)
Change to read:
USP Reference Standards 〈11〉
USP Phenylephrine Hydrochloride RS
USP Phenylephrine Related Compound F RS
(R)-2-Methyl-1,2,3,4-tetrahydroisoquinoline-4,8-diol hydrochloride monohydrate.
C10H13NO2 · HCl · H2O

